STERIS plc $STE Shares Acquired by Citigroup Inc.

Citigroup Inc. increased its stake in STERIS plc (NYSE:STE) by 23.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,769 shares of the medical equipment provider’s stock after acquiring an additional 27,600 shares during the period. Citigroup Inc. owned approximately 0.15% of STERIS worth $36,317,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of STE. Steigerwald Gordon & Koch Inc. purchased a new stake in STERIS during the 3rd quarter worth about $25,000. Cloud Capital Management LLC acquired a new position in shares of STERIS during the third quarter worth about $29,000. Spurstone Advisory Services LLC purchased a new stake in shares of STERIS during the second quarter worth approximately $29,000. Geneos Wealth Management Inc. increased its stake in shares of STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the period. Finally, TruNorth Capital Management LLC acquired a new stake in STERIS in the third quarter valued at approximately $37,000. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have commented on STE. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $275.20.

STERIS Trading Down 0.1%

NYSE STE opened at $246.83 on Wednesday. The firm’s fifty day moving average price is $255.84 and its 200 day moving average price is $251.59. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The company has a market capitalization of $24.21 billion, a price-to-earnings ratio of 34.43 and a beta of 1.03.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.STERIS’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be paid a dividend of $0.63 per share. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio is currently 35.15%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.